Departments of Health Sciences Research.
Laboratory Medicine and Pathology, and.
J Am Soc Nephrol. 2018 Jan;29(1):51-56. doi: 10.1681/ASN.2017030306. Epub 2017 Nov 2.
Fibrillary GN (FGN) is a rare primary glomerular disease. Histologic and histochemical features of FGN overlap with those of other glomerular diseases, and no unique histologic biomarkers for diagnosing FGN have been identified. We analyzed the proteomic content of glomeruli in patient biopsy specimens and detected DnaJ heat shock protein family (Hsp40) member B9 (DNAJB9) as the fourth most abundant protein in FGN glomeruli. Compared with amyloidosis glomeruli, FGN glomeruli exhibited a >6-fold overexpression of DNAJB9 protein. Sanger sequencing and protein sequence coverage maps showed that the DNAJB9 protein deposited in FGN glomeruli did not have any major sequence or structural alterations. Notably, we detected DNAJB9 in all patients with FGN but not in healthy glomeruli or in 19 types of non-FGN glomerular diseases. We also observed the codeposition of DNAJB9 and Ig- Overall, these findings indicate that DNAJB9 is an FGN marker with 100% sensitivity and 100% specificity. The magnitude and specificity of DNAJB9 overabundance in FGN also suggests that this protein has a role in FGN pathogenesis. With this evidence, we propose that DNAJB9 is a strong biomarker for rapid diagnosis of FGN in renal biopsy specimens.
纤维状肾小球肾炎 (FGN) 是一种罕见的原发性肾小球疾病。FGN 的组织学和组织化学特征与其他肾小球疾病重叠,目前尚未确定用于诊断 FGN 的独特组织学生物标志物。我们分析了患者活检标本中肾小球的蛋白质组内容,发现 DnaJ 热休克蛋白家族 (Hsp40) 成员 B9 (DNAJB9) 是 FGN 肾小球中第四丰富的蛋白质。与淀粉样变性肾小球相比,FGN 肾小球中 DNAJB9 蛋白的表达水平高出 6 倍以上。桑格测序和蛋白质序列覆盖图谱显示,沉积在 FGN 肾小球中的 DNAJB9 蛋白没有任何主要的序列或结构改变。值得注意的是,我们在所有 FGN 患者中均检测到了 DNAJB9,但在健康肾小球或 19 种非 FGN 肾小球疾病中均未检测到。我们还观察到 DNAJB9 与 Ig 的共沉积。总之,这些发现表明 DNAJB9 是 FGN 的标志物,具有 100%的灵敏度和 100%的特异性。FGN 中 DNAJB9 过度表达的幅度和特异性表明该蛋白在 FGN 发病机制中具有作用。有了这些证据,我们提出 DNAJB9 是快速诊断肾活检标本中 FGN 的有力生物标志物。